April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 07, 2025

Cannabis for Pain: ACP Issues Best Practices

New guidelines from the American College of Physicians address the limited benefits and potential harms of cannabis and cannabinoids for chronic noncancer pain management.

Conexiant

May 01, 2023

Virtual Reality in Retina

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Retinal Physician

March 08, 2023

RESET-RA trial explores a novel vagus nerve stimulation device for the treatment of rheumatoid arthritis

A research team at Baptist Health, located in south Florida, is participating in a randomized-controlled, parallel-assignment clinical trial. This trial explores a new vagus nerve stimulation (VNS) device called the SetPoint System.

Baptist Health South Florida

March 01, 2024

Study Published of RadiusXR VR Perimetry Platform

Results show a 0.94 correlation in mean deviation and statistical noninferiority to traditional methods for staging glaucoma.

Glaucoma Physician

March 07, 2025

New Clinical Guideline for Benzodiazepine Tapering Released

The new clinical practice guideline, developed in tandem by representatives from 10 medical societies, provides evidence-based and consensus recommendations for safe benzodiazepine tapering when risks outweigh benefits.

Conexiant

October 10, 2023

Psilocybin

The ASCO Post’s Integrative Oncology series is intended to facilitate the availability of evidence-based information on integrative and complementary therapies sometimes used by patients with cancer. ...

The ASCO Post

September 01, 2023

Collaborate on Concussion Management

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

July 17, 2023

Hyperammonemia Secondary to 5-Fluorouracil

A 65-year-old male with a history of multiple myeloma and colon cancer developed a rare and serious side effect after chemotherapy which was managed successfully. Treatment and care are crucial for such complications.

JADPRO